Global Sexually Transmitted Disease (STD) Testing Market 2024-2028
상품코드:1583592
리서치사:TechNavio
발행일:2024년 09월
페이지 정보:영문 176 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
성감염증(STD) 검사 시장(2024-2028년)
성감염증(STD) 검사 시장은 2023-2028년에 323억 7,000만 달러로 확대하며, 예측 기간 중 5.6%의 CAGR로 성장할 것으로 예측됩니다. 성감염증(STD) 검사 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25사의 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 이 시장은 STD의 유병률 증가, 유리한 상환 정책의 존재, 세계 각국 정부에 의한 구상의 증가에 의해 촉진되고 있습니다.
시장 범위
기준년
2024년
종료년
2028년
예측 기간
2024-2028년
성장 모멘텀
가속
전년대비(2024년)
5.22%
CAGR
5.6%
증분액
323억 7,000만 달러
향후 수년간 성감염증(STD) 검사 시장의 성장을 촉진하는 주요 요인의 하나로 성병의 신속 진단의 진보를 들고 있습니다. 또한 STD 및 신속 파트너 요법(EPT)에 관한 인식을 높이기 위해 다양한 조직의 관여가 증가하고 있는 것도 시장의 큰 수요로 연결됩니다.
The sexually transmitted disease (STD) testing market is forecasted to grow by USD 32.37 bn during 2023-2028, accelerating at a CAGR of 5.6% during the forecast period. The report on the sexually transmitted disease (STD) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of STDs, presence of favorable reimbursement policies, and increased initiatives by governments worldwide.
Market Scope
Base Year
2024
End Year
2028
Series Year
2024-2028
Growth Momentum
Accelerate
YOY 2024
5.22%
CAGR
5.6%
Incremental Value
$32.37 bn
Technavio's sexually transmitted disease (STD) testing market is segmented as below:
By Product
Laboratory testing device
POC testing device
By Disease Type
Chlamydia
Gonorrhea
Syphilis
Trichomoniasis
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the advances in rapid diagnosis of STDs as one of the prime reasons driving the sexually transmitted disease (STD) testing market growth during the next few years. Also, increasing involvement of various organizations to create awareness about STDs and expedited partner therapy (EPT) will lead to sizable demand in the market.
The report on the sexually transmitted disease (STD) testing market covers the following areas:
Sexually transmitted disease (STD) testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sexually transmitted disease (STD) testing market vendors that include AbbVie Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt. Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Goffin Molecular Technologies, Hangzhou Biotest Biotech, Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., LT Labs, Merck and Co. Inc., Ok Biotech Co Ltd., Priority STD Testing, QIAGEN NV, and RayBiotech Life Inc.. Also, the sexually transmitted disease (STD) testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Disease Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
